Correlation Between Ruentex Development and Alar Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ruentex Development and Alar Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ruentex Development and Alar Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ruentex Development Co and Alar Pharmaceuticals, you can compare the effects of market volatilities on Ruentex Development and Alar Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ruentex Development with a short position of Alar Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ruentex Development and Alar Pharmaceuticals.
Diversification Opportunities for Ruentex Development and Alar Pharmaceuticals
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Ruentex and Alar is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Ruentex Development Co and Alar Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alar Pharmaceuticals and Ruentex Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ruentex Development Co are associated (or correlated) with Alar Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alar Pharmaceuticals has no effect on the direction of Ruentex Development i.e., Ruentex Development and Alar Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ruentex Development and Alar Pharmaceuticals
Assuming the 90 days trading horizon Ruentex Development Co is expected to generate 0.41 times more return on investment than Alar Pharmaceuticals. However, Ruentex Development Co is 2.42 times less risky than Alar Pharmaceuticals. It trades about -0.14 of its potential returns per unit of risk. Alar Pharmaceuticals is currently generating about -0.1 per unit of risk. If you would invest 4,700 in Ruentex Development Co on September 4, 2024 and sell it today you would lose (160.00) from holding Ruentex Development Co or give up 3.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ruentex Development Co vs. Alar Pharmaceuticals
Performance |
| Timeline |
| Ruentex Development |
| Alar Pharmaceuticals |
Ruentex Development and Alar Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ruentex Development and Alar Pharmaceuticals
The main advantage of trading using opposite Ruentex Development and Alar Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ruentex Development position performs unexpectedly, Alar Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alar Pharmaceuticals will offset losses from the drop in Alar Pharmaceuticals' long position.| Ruentex Development vs. Ruentex Industries | Ruentex Development vs. Pou Chen Corp | Ruentex Development vs. Fubon Financial Holding | Ruentex Development vs. Cathay Financial Holding |
| Alar Pharmaceuticals vs. TWOWAY Communications | Alar Pharmaceuticals vs. Tainet Communication System | Alar Pharmaceuticals vs. Dimerco Data System | Alar Pharmaceuticals vs. Mitake Information |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |